CN104254599B - Using the biological protection of Lactobacillus paracasei bacterial strain - Google Patents
Using the biological protection of Lactobacillus paracasei bacterial strain Download PDFInfo
- Publication number
- CN104254599B CN104254599B CN201380018785.9A CN201380018785A CN104254599B CN 104254599 B CN104254599 B CN 104254599B CN 201380018785 A CN201380018785 A CN 201380018785A CN 104254599 B CN104254599 B CN 104254599B
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- bacterial strain
- lactobacillus paracasei
- food product
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000186605 Lactobacillus paracasei Species 0.000 title claims abstract description 118
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 109
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 85
- 235000013305 food Nutrition 0.000 claims abstract description 80
- 239000003814 drug Substances 0.000 claims abstract description 60
- 238000000034 method Methods 0.000 claims abstract description 34
- 239000012871 anti-fungal composition Substances 0.000 claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 claims abstract description 22
- 241000233866 Fungi Species 0.000 claims abstract description 13
- 239000007858 starting material Substances 0.000 claims description 86
- 235000013618 yogurt Nutrition 0.000 claims description 74
- 238000000855 fermentation Methods 0.000 claims description 53
- 230000004151 fermentation Effects 0.000 claims description 53
- 239000000203 mixture Substances 0.000 claims description 41
- 241000186660 Lactobacillus Species 0.000 claims description 30
- 229940039696 lactobacillus Drugs 0.000 claims description 29
- 235000013365 dairy product Nutrition 0.000 claims description 24
- 235000015142 cultured sour cream Nutrition 0.000 claims description 22
- 244000005700 microbiome Species 0.000 claims description 22
- 235000015140 cultured milk Nutrition 0.000 claims description 16
- 239000000758 substrate Substances 0.000 claims description 9
- 238000004113 cell culture Methods 0.000 claims description 8
- 235000014048 cultured milk product Nutrition 0.000 claims description 7
- 241000194017 Streptococcus Species 0.000 claims description 6
- 230000000843 anti-fungal effect Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 241000194036 Lactococcus Species 0.000 claims description 5
- 241000192132 Leuconostoc Species 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- 235000013372 meat Nutrition 0.000 claims description 5
- 244000144977 poultry Species 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 235000013336 milk Nutrition 0.000 description 86
- 239000008267 milk Substances 0.000 description 86
- 210000004080 milk Anatomy 0.000 description 86
- 235000013351 cheese Nutrition 0.000 description 78
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 48
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 48
- 241000894006 Bacteria Species 0.000 description 46
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 30
- 241000228143 Penicillium Species 0.000 description 20
- 229910052736 halogen Inorganic materials 0.000 description 19
- 150000002367 halogens Chemical class 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 16
- 235000014655 lactic acid Nutrition 0.000 description 15
- 239000004310 lactic acid Substances 0.000 description 15
- 241000203233 Aspergillus versicolor Species 0.000 description 14
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 13
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 13
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 13
- 238000003860 storage Methods 0.000 description 11
- 239000000356 contaminant Substances 0.000 description 10
- 238000011081 inoculation Methods 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 241000235395 Mucor Species 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 210000000481 breast Anatomy 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000001629 suppression Effects 0.000 description 9
- 241000228145 Penicillium brevicompactum Species 0.000 description 8
- 238000009928 pasteurization Methods 0.000 description 8
- 229940098377 penicillium brevicompactum Drugs 0.000 description 8
- 238000004321 preservation Methods 0.000 description 8
- 241000235546 Rhizopus stolonifer Species 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 244000253911 Saccharomyces fragilis Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000001857 anti-mycotic effect Effects 0.000 description 6
- 239000002543 antimycotic Substances 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 5
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 241000235649 Kluyveromyces Species 0.000 description 3
- 241001138401 Kluyveromyces lactis Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241001507677 Penicillium commune Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 108010046377 Whey Proteins Proteins 0.000 description 3
- 102000007544 Whey Proteins Human genes 0.000 description 3
- 241000235015 Yarrowia lipolytica Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000007747 plating Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229940108461 rennet Drugs 0.000 description 3
- 108010058314 rennet Proteins 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000186425 Acidipropionibacterium jensenii Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001131796 Botaurus stellaris Species 0.000 description 2
- 241000186146 Brevibacterium Species 0.000 description 2
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241000235035 Debaryomyces Species 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 2
- 240000006024 Lactobacillus plantarum Species 0.000 description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 2
- 241000194041 Lactococcus lactis subsp. lactis Species 0.000 description 2
- 241001507662 Penicillium crustosum Species 0.000 description 2
- 241000864269 Penicillium nalgiovense Species 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 235000014969 Streptococcus diacetilactis Nutrition 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 230000000513 bioprotective effect Effects 0.000 description 2
- 235000015155 buttermilk Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000010269 danmu Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000015090 marinades Nutrition 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241001530515 Candida sake Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- 241000235036 Debaryomyces hansenii Species 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000360590 Erythrites Species 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 241001112724 Lactobacillales Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 244000172809 Leuconostoc cremoris Species 0.000 description 1
- 235000017632 Leuconostoc cremoris Nutrition 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 244000131099 Macrotyloma uniflorum Species 0.000 description 1
- 235000012549 Macrotyloma uniflorum Nutrition 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000131448 Mycosphaerella Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000985530 Penicillium glabrum Species 0.000 description 1
- 241000960405 Penicillium paneum Species 0.000 description 1
- 241000521553 Pichia fermentans Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000008953 bacterial degradation Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021105 fermented cheese Nutrition 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 235000011617 hard cheese Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 235000020121 low-fat milk Nutrition 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000021116 parmesan Nutrition 0.000 description 1
- 229940094461 penicillium glabrum Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000008924 yoghurt drink Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C13/00—Cream; Cream preparations; Making thereof
- A23C13/12—Cream preparations
- A23C13/16—Cream preparations containing, or treated with, microorganisms, enzymes, or antibiotics; Sour cream
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
- A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
- A23C19/068—Particular types of cheese
- A23C19/076—Soft unripened cheese, e.g. cottage or cream cheese
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3571—Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Agronomy & Crop Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Communicable Diseases (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
Abstract
The present invention relates to biological protection field, more particularly to the Lactobacillus paracasei CHCC14676 bacterial strains that deposit number is DSM25612.Moreover, the present invention relates to a kind of antifungal composition comprising the bacterial strain, a kind of antifungal composition, the food product comprising such a antifungal composition, feed product and medicine comprising the bacterial strain and at least one Lactobacillus rhamnosus strain, a kind of method for manufacturing such a food product, feed product and medicine, a kind of reduction such a food product, feed product and the fungi of medicine and the method for mould bacterial content and the purposes of the antifungal composition.
Description
Technical field
The present invention relates to biological protection field, more particularly to the Lactobacillus paracasei that deposit number is DSM25612
(Lactobacillus paracasei) CHCC14676 bacterial strains.Moreover, the present invention relates to a kind of anti-true comprising the bacterial strain
Bacteria composition, one kind include the bacterial strain and at least one Lactobacillus rhamnosus (Lactobacillus rhamnosus) bacterial strain
Antifungal composition, food product, feed product and medicine comprising such a antifungal composition, one kind manufactures such a food
The method of product, feed product and medicine, a kind of fungi and mould bacterial content for reducing such a food product, feed product and medicine
Method, and the purposes of the antifungal composition.
Technical background
For many years, lactic acid bacteria is used for the storage life for extending food product always.Lactic acid bacteria produces breast during the fermentation
Acid and other organic acids, so as to reduce the pH value of the food product, make them unsuitable for such as pathogenetic bacteria, yeast and fungi
The growth of unwanted microorganism.
In addition, some lactic acid bacterias also produce the metabolin with antimicrobial acivity.
U.S. Patent application US2011/0045134 is related to Lactobacillus paracasei and assigns antifungal property to fermented dairy product
Purposes.
European patent application EP1442113 is related to propionibacterium jensenii (Propionibacterium jensenii) and all
Such as the mixture of the kind (Lactobacillus sp.) of the lactobacillus of Lactobacillus paracasei, it has antimicrobial acivity, is used for
Biological protection.
But, it is still desirable to there is the anti-true of improvement as single bacterial strain or with what other biological protectiveness bacterial strain was combined
The Bioprotective of bacterium effect.
The content of the invention
It is an object of the invention to provide can be used as Bioprotective to have efficient novel lactic acid bacteria strains.
The present inventor is by largely screening and studying the biological protection culture it has been found that with the market commercialization
Compare, some Lactobacillus paracasei bacterial strain confrontation yeast and the significantly higher effect of mould.
The present inventor is it has been further discovered that a certain group of lactic acid bacteria shows significant association when being combined with another group of lactic acid bacteria
Same anti-microbial effect., it is surprising that the anti-microbial effect of this combined two groups of bacteriums is more than this two groups of bacteriums lists
The summation of only effect.
Brief description of the drawings
Fig. 1 shows growth of the mould in the Yoghourt containing 1.5% fat, and the Yoghourt is individually by starter culture YF-
L901 (top row), by starter culture YF-L901 together with HOLDBACTMYM-B (center row) and by starter culture YF-L901
Fermented together with Lactobacillus paracasei CHCC14676.Target contaminant is from left to right added with the concentration referred in text respectively:It is short
It is close mould (Penicillium brevicompactum) (M1), penicillium communne (Penicillium commune) (M6), variegated
Aspergillus (Aspergillus versicolor) (M7) and light spore mould (Penicillium glabrum) (M8).The Yoghourt
It has been incubated at 7 ± 1 DEG C 61 days.
Fig. 2 shows the inferior Dbaly yeast (Debaryomyces of the Chinese added into the Yoghourt containing 1.5% fat
Hansenii the cell count of bacterium) is separated, the Yoghourt is individually by starter culture YF-L901 (reference) or by starter culture
YF-L901 is together with HOLDBACTMYM-B cultures (HoldBac YM-B), by starter culture YF-L901 together with HOLDBACTM
YM-C cultures (HoldBac YM-C), or by starter culture YF-L901 together with Lactobacillus paracasei bacterial strain CHCC14676
(14676) ferment together.Yoghourt is stored in 7 ± 1 DEG C and analyzed in reasonable time interval.
Fig. 3 shows growth of the mould on flat board, the flat board be prepared in individually by starter culture (reference, first
Width figure), by starter culture together with Lactobacillus paracasei CHCC14676 (the second width figure), by starter culture together with rhamnose
Lactobacillus CHCC5366 (the 3rd width figure), or by starter culture together with Lactobacillus paracasei CHCC14676 and rhamnose breast bar
The milk of bacterium CHCC5366 combination (the 4th width figure) fermentation.A left side is moved to the concentration referred in text clockwise from the upper left of flat board
It is lower to add target contaminant respectively:Receive ground mould (Penicillium nalgiovense), penicillium communne (Penicillium
Commune), aspergillus versicolor (Aspergillus versicolor) and skin fall mould (Penicillium crustosum).Institute
Flat board is stated to be incubated at 7 ± 1 DEG C 12 days.
Fig. 4 shows growth of the mould on flat board, the flat board be prepared in individually by starter culture (reference, first
Width figure), by starter culture together with Lactobacillus paracasei CHCC14676 (the second width figure), by starter culture together with rhamnose
Lactobacillus CHCC14226 (the 3rd width figure) or by starter culture together with Lactobacillus paracasei CHCC14676 and rhamnose breast bar
The milk of bacterium CHCC14226 combination (the 4th width figure) fermentation.Moved to clockwise from the upper left of flat board with the concentration referred in text
Target contaminant is added respectively in lower-left:Receive ground mould (Penicillium nalgiovense), penicillium communne (Penicillium
Commune), aspergillus versicolor (Aspergillus versicolor) and skin fall mould (Penicillium crustosum).Institute
Flat board is stated to be incubated at 7 ± 1 DEG C 12 days.
Fig. 5 shows growth of the mucor (Mucor ssp.) in Greek style Yoghourt (Greek yoghurt), described uncommon
Cured formula Yoghourt is prepared in the milk (left side cup) only to be fermented by starter culture, or is done in Lactobacillus rhamnosus CHCC5366 and pair
Lactobacillus paracasei CHCC14676 all in the presence of the milk (right side cup) that ferments.
Fig. 6 shows growth of the rhizopus stolonifer (Rhizopus stolonifer) in Greek style Yoghourt, the Greek style
Yoghourt is prepared in only by starter culture (R, i.e. reference), by starter culture and HOLDBACTMYM-B (YM-B), is trained by bottle opener
Thing and Lactobacillus rhamnosus CHCC5366 (5366) are supported, or by starter culture and Lactobacillus rhamnosus CHCC5366 and secondary cheese
The milk of lactobacillus CHCC14676 combination (5366+14676) fermentation.
Fig. 7 shows penicillium brevicompactum (M1), penicillium communne (M6), aspergillus versicolor (M7) and light spore mould (M8) in sour cream
In growth, the sour cream is prepared in only by starter culture (top go);By starter culture and HOLDBACTMYM-B (in
Between row);Or combination (the bottom by starter culture and Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC12697
OK) the milk of fermentation.
Fig. 8 shows growth of the inferior Dbaly yeast of the Chinese in sour cream, and the sour cream is prepared in only by bottle opener culture
Thing (reference);By starter culture and HOLDBACTMYM-B(YM-B);Or by starter culture, Lactobacillus paracasei
The milk of CHCC14676 and Lactobacillus rhamnosus CHCC12697 (12697+14676) fermentations.
Fig. 9 shows saccharomyces cerevisiae (Saccharomyces cerevisiae) in white halogen cheese (white brine
Cheese the growth on), the white halogen cheese are prepared in only by starter culture (reference);By starter culture and HOLDBACTM
YM-B(YM-B);Or by starter culture, Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC5366 (5366+
14676) milk of fermentation.
Figure 10 shows life of the kluyveromyces marxianus (Kluyveromyces marxianus) on white halogen cheese
Long, the white halogen cheese is prepared in only by starter culture (reference);By starter culture and HOLDBACTMYM-B(YM-B);
Or by starter culture, Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC5366 (5366+14676) fermentation
Milk.
Figure 11 shows growth of the penicillium communne on white halogen cheese, and the white halogen cheese is prepared in only by starter culture
(R, i.e. reference);By starter culture and HOLDBACTMYM-B(YM-B);Or by starter culture, Lactobacillus paracasei
The milk of CHCC14676 and Lactobacillus rhamnosus CHCC5366 (5366+14676) fermentations.
Figure 12 shows life of the mould Pan Shi moulds (Penicillium paneum) in the Yoghourt containing 1.5% fat
Long, the Yoghourt is prepared in by single starter culture (R, i.e. reference), by starter culture and HOLDBACTM YM-B(YM-
B), by starter culture and Lactobacillus rhamnosus CHCC5366 (5366), or by starter culture and Lactobacillus rhamnosus
The milk that CHCC5366 and Lactobacillus paracasei CHCC14676 combination (5366+14676) is fermented.
Figure 13 shows that mould skin falls growth of the mould in the Yoghourt containing 1.5% fat, and the Yoghourt is prepared in by list
Only starter culture (top row), by starter culture and HOLDBACTMYM-B (the second row), by starter culture and rhamnose
Lactobacillus CHCC5366 (the third line), or by starter culture and Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei
The milk of CHCC14676 combination (last column) fermentation.Target contaminant is added with the concentration of 100 spore/cups, and it is described
Yoghourt is incubated 36 days in 7 ± 1 DEG C (left columns), 12 ± 1 DEG C (intermediate hurdles) or 22 ± 1 DEG C (right column).
Embodiment
Definition
As used herein, term " lactic acid bacteria " refers to gram-positive micro- aerobic or anaerobism bacterium, and its sugar fermentation produces
Acid, including lactic acid are main caused acid.Industrial most useful genus lactubacillus are in " lactobacillus (Lactobacillales) "
Mesh, it includes lactococcus (Lactococcus spp.), streptococcus (Streptococcus spp.), lactobacillus
(Lactobacillus spp.), Leuconostoc (Leuconostoc spp.), pseudo- Leuconostoc
(Pseudoleuconostoc spp.), Mycosphaerella (Pediococcus spp.), brevibacterium (Brevibacterium
) and enterococcus spp (Enterococcus spp.) spp..These bacteriums often combine individually or with other lactic acid bacterias and are used as eating
Product culture.
Term " food " is intended to also include cheese.Term " cheese " is interpreted to embrace any cheese, including hard cheese,
Semi-rigid cheese and soft cream, such as following types of cheese:Ka Teji cheese (Cottage), phenanthrene reach cheese (Feta), cut
Up to cheese (Cheddar), Palma cheese (Parmesan), cheese (Mozzarella), angstrom door tal fibre cheese do not draw in Surrey
(Emmentaler), red rich cheese (Danbo), up to cheese (Gouda), Ai Danmu cheese (Edam), Fei Dashi cheese
(Feta-type), blue cheese (blue cheeses), halogen cheese (brine cheese), card awns Bel cheese (Camembert)
With cheese in cloth (Brie).Skilled in the art realises that how coagulation is transformed into cheese, method can be found from document,
See, for example, Kosikowski, F.V and V.V.Mistry, " Cheese and Fermented Milk Foods ", 1997,
Three editions, F.V.Kosikowski, L.L.C.Westport, CT. is as used herein, will have dense less than 1.7% (w/w) NaCl
The cheese of degree is referred to as " less salt cheese ".
The lactic acid bacteria for being typically included the bacterium of lactobacillus species and milk-globule strain is supplied to dairy industry, itself or with freezing
Or the form of lyophilized culture is bred for batch bottle opener, or with so-called " direct putting type " (" Direct Vat Set ") (DVS)
Culture form, it is intended to be directly inoculated into and be used for the breast system for producing such as fermented-milk products or cheese in round or fermenter
Product.Such a lactic acid bacteria culture is commonly referred to as " starter culture " or " bottle opener ".
Term " mesophile " herein refers to grows most vigorous microorganism under moderate temperature (15 DEG C to 40 DEG C).Industry
Upper most useful mesophili bacteria includes lactococcus and Leuconostoc.Term " mesophilic digestion " herein refers at about 22 DEG C
Fermentation at a temperature of about 35 DEG C.Term " mesophilic digestion dairy products " refers to the mesophilic digestion institute by medium temperature starter culture
The fermented-milk products of preparation, and including such as buttermilk, yogurt (sour milk), cultured milk (cultured milk), Si Mei
The fermentation of tower that sour cream (smetana), sour cream and fresh cheese (such as quark cheese, tvarog cheese and cream cheese)
Dairy products.
Term " Thermophilic Bacteria " herein refers in the most vigorous microorganism of the temperature growth higher than 43 DEG C.It is industrial most useful
Thermophilic bacteria include streptococcus and lactobacillus.Term " hot fermentation " herein refers to higher than about 35 DEG C (such as
About 35 DEG C to about 45 DEG C) at a temperature of fermentation.Term " hot fermentation dairy products " refers to by thermophilic starter culture
Fermented-milk products prepared by hot fermentation, and including such as hair of solidification type yoghourt, stirred yoghurt and drinking yoghourt
Ferment dairy products.
Term " milk " should be understood by entering to any mammal of such as milk cow, sheep, goat, buffalo or camel
The galactosis thing of residual that row is milked and obtained.In a preferred embodiment, milk is milk.Term milk also includes former by plant
Expect the protein/fat solution of manufacture, such as big soymilk.
Term " milk substrate " can be can the method according to the invention experience fermentation any raw milk's raw material and/or processing
Milk material.Therefore, useful milk substrate includes but is not limited to solution/suspension of any milk comprising protein or class dairy products,
Such as whole milk or low fat milk, defatted milk, buttermilk, recovery milk powder, condensed milk, dried milk, whey, whey penetrant, lactose, lactose
Crystalline mother solution, whey protein concentrate or cream.Obviously, milk substrate is probably derived from any mammal, for example, as basic
Upper pure mammal milk restores milk powder.
Before fermentation, milk substrate can be homogenized according to procedures known in the art and pasteurization.
As used herein, " homogenize " and mean and be thoroughly mixed to obtain solvable suspension or emulsion.If fermenting
Homogenized before, then its purpose is to which milk fat is broken for into less size, it is no longer separated with milk.This can
To be realized by forcing milk under high pressure through aperture.
As used herein, " pasteurization ", which is meant, is handled milk substrate, to reduce or eliminate such as microorganism
Living Organism presence.Preferably, pasteurization is by maintaining set period to realize assigned temperature.It is described to specify
Temperature is generally realized by heating.Temperature and duration can be selected, to kill or inactivate some bacteriums, such as it is harmful thin
Bacterium.Next quick cooling step can be carried out.
In the method for the present invention, " fermentation " mean by the effect of microorganism by it is carbohydrate-modifying be alcohol or
Acid.Preferably, it is lactic acid that the fermentation in method of the invention, which is included Lactose conversion,.
Be intended for use in dairy products production in fermentation process be it is well known that and those skilled in the art will be appreciated that such as
What suitable process conditions of selection, such as temperature, oxygen, the quantity and characteristic of microorganism, and process time.Obviously, to hair
Ferment condition carry out selection be in order to contribute to the present invention realization, i.e., in order to obtain the dairy products of solid-state form (such as cheese) or
The dairy products (such as fermented-milk products) of liquid form.
The present invention composition offered the advantage that, such as on food product, feed product and medicine and
In the mankind and mammal, the unwanted microorganism selected from fungi, bacterium and its mixture can be suppressed.Especially expected resistance
Only and/or suppress such as yeast and mould fungi growth.Therefore, in a preferred embodiment, term " resists micro- life
Thing " should be understood " antimycotic ".
Term " unwanted microorganism " herein refers to pathogenic microorganism and/or can make food product, feed product
Or the microorganism that medicine is rotten, such as bacterium and fungi, such as yeast.The present invention composition offered the advantage that, example
Such as on food product, feed product and medicine and in the mankind and mammal, selected from fungi, bacterium and its mixture
Unwanted microorganism can be suppressed.The growth of the fungi of especially expected prevention and/or suppression such as yeast and mould.
The term " suppression " related to yeast and mould is meant, for example, the growth of yeast and mould or quantity or dense
Spend in the food product for example comprising the bacterial strain according to the present invention and/or on its surface than in the food not comprising such bacterial strain
It is low in product product and/or on its surface.
Herein, term " mutant " should be understood that for example, by genetic engineering, radiation and/or chemical treatment hand
Bacterial strain derived from section from the bacterial strain of the present invention.Preferably, the mutant is a kind of mutant of functional equivalent, for example, with mother
Bacterial strain has the mutant of characteristic (such as on antifungal property) that is substantially the same or improving.Such mutant is this
A part for invention.Especially, term " mutant " refers to by making the bacterial strain of the present invention undergo at any conventional use of mutagenesis
The bacterial strain managed and obtained, or spontaneous caused mutant, the mutagenic treatment include using such as ethyl methane sulfonate (EMS) or N- first
The chemical mutagen processing of base-N'- nitro-N-nitroguanidines (NTG), with UV light processings.Mutant may experienced mutagenesis for several times
Handle (single treatment should be understood that a mutagenesis steps and subsequent screening/selection step), still, it is presently preferred to carry out
No more than 20 times, or no more than 10 times, or no more than 5 times processing (or screening/selection step).In a currently preferred mutation
In body, compared to mother strains, 5%, or less than 1% is less than in its bacterial genomes, or the nucleotides even less than 0.1% is by quilt
Another nucleotides substitution, or lacked.
Contrary is explicitly indicated that unless otherwise indicated herein or by context, in the context of the explanation present invention
Term " a (one/mono-/a kind of) " that (particularly in the context of claim) uses, " an (one/mono-/a kind of) " and
" should/described " and similar term should be understood that and cover odd number and plural number.Unless otherwise indicated, term "comprising", " tool
Have ", " comprising " and " containing " be construed as open-ended term (representing " including but is not limited to ").Unless separately have herein
Bright, number range described herein is provided merely as being individually recited the simple statement side for each discrete values for falling into the scope
Method, and each discrete values are incorporated into specification as being individually recited in the text.Unless separately have herein
Illustrate or contrary is explicitly indicated that by context, all methods described herein can be in any suitable order
Implement.Unless otherwise stated, provided herein is any and all embodiment or citing language (such as " such as ") use
It is intended merely for that the present invention is better described, not as limiting the scope of the present invention.All language in specification
The element that shall not be construed as any undesired protection is necessary for implementing the present invention.
Embodiment of the present invention and aspect
The present inventor is to Lactobacillus plantarum (Lactobacillus plantarum), Lactobacillus paracasei and rhamnose
200 candidate strains of lactobacillus are screened, to find the most effective of the wide scope microorganism of confrontation such as yeast and mould
Single bacterial strain or double bacterial strains combination.
Screening is carried out in the matrix based on milk with simulating the model analysis of mesophilic digestion dairy products as far as possible, the matrix
In added with containing or not contain the related starter culture of biological protection candidate, and the matrix with mesophilic digestion
It is fermented under conditions of dairy products correlation.Target organs are isolated from medium temperature fermented-milk products.Using below both as
Benchmark:From Denis company of Denmark (Danisco A/C, Denmark) HOLDBACTMThe lactic acid bacteria of culture purifying, Yi Jihan
There are lactic acid bacteria and the complete HOLDBAC both bacterium acidi propioniciTMYM-B and HOLDBACTMYM-C cultures.
The model analysis is described in european patent application EP11161609.0.
When detecting for 25 DEG C, find to have in Lactobacillus paracasei and Lactobacillus rhamnosus 17 kinds of candidate strains usually can be with
The benchmark lactic acid bacteria considerably or compared with it more preferably suppresses 12 kinds of instruction fungies.
When being detected on Yoghourt, a bacterial strain of Lactobacillus paracasei, i.e., Germany is preserved in deposit number DSM25612
Microorganism and the Lactobacillus paracasei bacterial strain CHCC14676 of Cell Culture Collection (DSMZ), suppressing yeast and mould
Aspect is shown than commercially available biological protection culture significantly more preferably.
As the inhibition of bacterial strain confrontation yeast and mould can be described by the embodiment in following article, pass through by
Fermented-milk products store one section of suitable storage time to determine at a suitable temperature.
In general, the suitable temperature of this method should be implemented depending on specific food product, feed product or medicine lead to
The temperature for being often stored and/or manufacturing.The temperature of the product is generally stored between 5 DEG C and 26 DEG C, it is preferable that the temperature
It is about 8 DEG C.
Storage time at said temperatures depends on the time that the food product, feed product or medicine generally store
(storage life).Storage time is typically 5-65 days, preferably 7-60 days, more preferably 7-28 days, and even further preferably, the storage
Time is about 21 days, and more preferably up to 60 days or more.
Therefore, the first aspect of the present invention is related to Lactobacillus paracasei bacterial strain, and it is selected from the group consisted of:With preservation
Numbering DSM25612 is preserved in the Lactobacillus rhamnosus strain of German microorganism and Cell Culture Collection (DSMZ)
CHCC14676, and by its derivative mutant strain.
Therefore, in addition to preservation strain mentioned above, the present invention also relates to the mutant derived from this bacterial strain,
That is, described mutant is obtained by using the preservation strain CHCC14676 for parent material.The mutant strain can be such as
The preservation strain is derived from by following means:Genetic engineering, radiation, UV light, chemical treatment and/or induced gene group change
Method.It will be suppressed according to mutant of the present invention and/or prevent some bacteriums or fungi, the growth of preferred mould.It is excellent
Selection of land, when in analysis as described in Example 1, using its growth by repressed penicillium brevicompactum, penicillium communne, variegated
One of mould of the inferior Dbaly yeast of aspergillus, the Chinese or light spore mould as be measured with reference to organism when, the mutant and
Its mother strains, which is compared, has substantially at least 80% or more, at least 90% or more, at least 95% or more, or even as high as
100% or more anti-mycotic efficiency.
It will be apparent to those skilled in the art that be parent material by using the bacterial strain of the preservation, skilled reader by
Conventional mutagenesis or again isolation technics can routinely obtain keep correlated characteristic described herein and advantage enter one
Mutant of step or derivatives thereof.Therefore, the term of first aspect is related to by using described " by its derivative mutant strain "
The mutant strain that the bacterial strain of preservation is obtained by parent material.
Second aspect is related to a kind of antifungal composition, and it does comprising at least one pair according to the first aspect of the invention
Lactobacillus paracasei bacterial strain, preferably Lactobacillus paracasei bacterial strain CHCC14676.
When from different Lactobacillus rhamnosus strain combined test Lactobacillus paracasei bacterial strain CHCC14676, exceed to anticipate
Material ground finds that these are combined even than single any bacterial strain more preferably, in the case of the total concentration identical of cell.One
In individual embodiment, the present invention relates to Lactobacillus paracasei bacterial strain CHCC14676's and Lactobacillus rhamnosus strain CHCC5366
Combination.In another embodiment, the present invention relates to Lactobacillus paracasei bacterial strain CHCC14676 and Lactobacillus rhamnosus strain
CHCC14226 combination.Also in another embodiment, the present invention relates to Lactobacillus paracasei bacterial strain CHCC14676 and mouse
Lee's sugar lactobacillus strain CHCC12697 combination.These combinations seem than the benchmark culture from Denis company of Denmark
HOLDBACTMYM-B and HOLDBACTMYM-C is more effective.
Therefore, in a preferred embodiment, it is related to the present invention relates to antimicrobial compositions and more preferably anti-true
Bacteria composition, the composition includes is preserved in German microorganism and Cell Culture Collection with deposit number DSM25612
(DSMZ) Lactobacillus paracasei bacterial strain CHCC14676 or its derivative mutant, and at least one Lactobacillus rhamnosus bacterium
Strain.Preferably, at least one Lactobacillus rhamnosus strain is selected from the Lactobacillus rhamnosus for DSM24616 by deposit number
Lactobacillus rhamnosus strain CHCC14226 that bacterial strain CHCC12697, deposit number are DSM24652, deposit number are
DSM23035 Lactobacillus rhamnosus strain CHCC5366, and the group that the mutant strain derived from these preservation strains forms.
The present invention in one aspect thus a kind of antimicrobial compositions and more preferably antifungal composition are provided, it is described
Composition includes Lactobacillus paracasei bacterial strain CHCC14676 or its derivative mutant, and Lactobacillus rhamnosus strain
CHCC14226 or its derivative mutant.On the other hand, the present invention provides a kind of antimicrobial and more preferably antimycotic group
Compound, it includes at least Lactobacillus paracasei bacterial strain CHCC14676 or by its derivative mutant, and Lactobacillus rhamnosus bacterium
Strain CHCC5366 or by its derivative mutant.In yet a further aspect, the present invention provides a kind of antimicrobial compositions and more excellent
Antifungal composition is selected, the composition includes at least Lactobacillus paracasei bacterial strain CHCC14676 or its derivative mutant, with
And Lactobacillus rhamnosus strain CHCC12697 or its derivative mutant.Preferably, the secondary cheese in the present composition
The combination of lactobacillus strain and the Lactobacillus rhamnosus strain cooperates with terms of their antimicrobial and/or antifungal activity
Effect.
The antifungal composition typically comprises the bacterium of conc forms, including the concentrate for freezing, drying or freezing,
The viable cell concentrations that the bacterium of the conc forms typically has are in every gram of composition 104To 1012Cfu (colony forming unit)
Scope, including every gram of composition at least 104Cfu, such as at least 105Cfu/g, for example, at least 106Cfu/g, such as at least
107Cfu/g, for example, at least 108Cfu/g, such as at least 109Cfu/g, for example, at least 1010Cfu/g, such as at least 1011cfu/g。
Therefore, composition of the invention preferably to freeze, dry or lyophilized form exist, for example, as direct putting type (DVS) culture.
However, as used herein, the composition is also likely to be to be suspended in the freezing, the cell concentration thing dried or freezed such as
The liquid obtained after in the fluid matrix of water or PBS.When the composition of the present invention is suspension, the concentration of living cells
In every milliliter of composition 104To 1012Cfu (colony forming unit) scope, including every milliliter of composition at least 104Cfu, such as
At least 105Cfu/ml, for example, at least 106Cfu/ml, such as at least 107Cfu/ml, for example, at least 108Cfu/ml, such as at least
109Cfu/ml, for example, at least 1010Cfu/ml, such as at least 1011cfu/ml。
The composition can contain antifreezing agent and/or conventional additives as further composition, the conventional additives
Nutrition including such as yeast extract, sugar and vitamin (such as vitamin of vitamin A, C, D, K or vitamin B complex)
Element.Can be added to the present invention composition in suitable antifreezing agent be improve microorganism cold resistance composition, such as sweet dew
Alcohol, sorbierite, sodium tripolyphosphate, xylitol, glycerine, gossypose, maltodextrin, erythrite, threitol, trehalose, grape
Sugar and fructose.Other additives may include, such as carbohydrate, flavor enhancement, mineral matter, enzyme (such as rennet
(rennet), lactase and/or phosphatidase).
In the composition of the invention comprising Lactobacillus paracasei bacterial strain CHCC14676 and Lactobacillus rhamnosus strain,
Ratio between Lactobacillus paracasei bacterial strain CHCC14676 and the Lactobacillus rhamnosus strain, such as Lactobacillus paracasei are thin
Ratio between the concentration or quantity of bacterium and the concentration or quantity of Lactobacillus rhamnosus bacterium, preferably 1:100 to 100:1, it is excellent
Elect 1 as:10 to 10:1.
The antifungal composition of the present invention can be with being easily degraded by microorganisms and/or easily by times of yeast and mould contamination
What food product, feed product and medicine are used in connection with.These include but is not limited to fruits and vegetables (including derived product), paddy
Thing and cereal derived product, dairy products, meat, poultry and marine products class.In particularly preferred embodiments, the composition
It is used in connection with dairy products and/or meat and poultry.In a preferred embodiment, composition of the invention is used for all
Additive is used as in such as preparation of Yoghourt, tvarog cheese, sour cream, cream cheese, white halogen cheese dairy products.
In a preferred embodiment, composition of the invention is used for antimycotic, such as yeast and mould.This meaning
Taste the composition and is used to suppress and/or prevent during dairy processing industry, especially in milk fermentation process, causes to pollute
Fungi growth.The composition of the present invention can be used in, such as suppress and/or prevent the growth of yeast, such as with subordinate's
Yeast:Kluyveromyces (Klyveromyces) (such as kluyveromyces marxianus (K.marxianus), Kluyveromyces Lactis dimension
Yeast (K.lactis)), pichia (Pichia) (such as fermentation Pichia pastoris (P.fermentans)), Ye Shi saccharomyces
(Yarrowia) (such as Yarrowia lipolytica (Y.lipolytica)), candida (Candida) (such as pure mellow wine vacation silk ferment
Female (C.sake)) etc.;Or suppress and/or prevent the growth of mould, such as from the mould of subordinate:Penicillium
(Penicillium) (such as receive ground mould, penicillium communne, skin fall mould, penicillium brevicompactum, light spore mould), mucor (Mucor
Spp.), cladosporium category (Cladiosporium ssp.), aspergillus (Aspergillus) (such as aspergillus versicolor), De Bali ferment
Mother's category (Debaryomyces) (such as inferior Dbaly yeast of the Chinese (D.hansenii)) etc..It is particularly preferred that use the present invention
Composition suppress and/or prevent the growth such as sowed:Kluyveromyces marxianus, Yarrowia lipolytica, receive ground mould, branch spore
Pseudomonas, penicillium communne, mucor, penicillium brevicompactum, aspergillus versicolor, skin fall mould, Kluyveromyces lactis and/or Han Xunde Balis
Yeast.
Antifungal composition according to the second aspect of the invention is also used as medicine, and it is true to be preferred for treatment pathogenicity
Bacterium infects, such as medicine of pathogenicity yeast infection.
In the third aspect, the present invention relates to comprising Lactobacillus paracasei bacterial strain according to the first aspect of the invention or according to
Food product, feed product or the medicine of the antifungal composition of the second aspect of the present invention.
In a preferred embodiment, the food product, feed product or medicine are food product.
In a further preferred embodiment, such a food product be selected from by fruit and fruit derived product, vegetables and
What vegetables derived product, cereal and cereal derived product, dairy products, meat, poultry and marine products category and its mixture formed
Group.
In one even more preferably embodiment, the food product is dairy products, preferably mesophilic digestion dairy products
Or hot fermentation dairy products, such as fresh cheese, Yoghourt, sour cream or tvarog cheese.
In a further preferred embodiment, the food product is meat or poultry.
In a preferred embodiment, the food product, feed product or medicine are medicines.
Preferably, the medicine is to can be used for applying human or animal antimycotic combination according to the second aspect of the invention
Thing, with the product for suppressing pathogenic microbes and mitigating the symptom related to pathogenic microbes.The example of such a symptom includes
The symptom related to yeast infection.In this kind of embodiment, the medicine can be the unit dose for including antifungal composition
Type.Preferably, the unit dosage forms are capsule or tablet.However, the unit dosage forms can also be suitable for being administered to mucous membrane or
Skin, and therefore exist in the form of paste, emulsifiable paste, ointment etc..
The fourth aspect of the present invention is related to a kind of food product being used to manufacture according to the third aspect of the invention we, feed production
The method of product or medicine, methods described, which is included in the manufacturing process of the food product, feed product or medicine, adds at least
A kind of Lactobacillus paracasei bacterial strain according to the first aspect of the invention or antimycotic combination according to the second aspect of the invention
Thing.Preferably, methods described is additionally included in manufacturing process the step of controlling Fabrication parameter, described at least one secondary dry to cause
The concentration of Lactobacillus paracasei bacterial strain remains constant or improved.
In a preferred embodiment, the concentration of at least one Lactobacillus paracasei bacterial strain is produced for the food
At least the 1 × 10 of product, feed product or medicine6At least the 1 of cfu/g or respectively described food products, feed product or medicine
×106Cfu/ml, or at least the 1 × 10 of the surface of respectively described food product, feed product or medicine5cfu/cm2.It is preferred that
Ground, the concentration of at least one Lactobacillus paracasei bacterial strain is the food product, feed product or medicine at least 5 ×
106At least the 5 × 10 of cfu/g or respectively described food products, feed product or medicine6Cfu/ml, or respectively described food
At least the 5 × 10 of the surface of product, feed product or medicine5cfu/cm2, it is such as the food product, feed product or medicine
At least 1 × 107At least the 1 × 10 of cfu/g or respectively described food products, feed product or medicine7Cfu/ml, or each
For at least the 1 × 10 of the surface of the food product, feed product or medicine6cfu/cm2, it is such as the food product, feed
At least the 5 × 10 of product or medicine7At least the 5 × 10 of cfu/g or respectively described food products, feed product or medicine7cfu/
Ml, or at least the 5 × 10 of the surface of respectively described food product, feed product or medicine6cfu/cm2。
When by addition include Lactobacillus paracasei bacterial strain CHCC14676 or its derivative mutant and at least one sandlwood
When sugared lactobacillus strain is to manufacture the food product, feed product or medicine, Lactobacillus paracasei bacterial strain CHCC14676 or its
The concentration of derivative mutant and/or the concentration of at least one Lactobacillus rhamnosus strain be respectively the food product,
At least the 1 × 10 of feed product or medicine6Cfu/g or respectively described food products, feed product or medicine at least 1 ×
106Cfu/ml, or at least the 1 × 10 of the surface of respectively described food product, feed product or medicine5cfu/cm2.Preferably,
The concentration and/or at least one Lactobacillus rhamnosus of Lactobacillus paracasei bacterial strain CHCC14676 or its derivative mutant
The concentration of bacterial strain is respectively at least the 5 × 10 of the food product, feed product or medicine6Cfu/g or respectively described food
At least the 5 × 10 of product, feed product or medicine6Cfu/ml, or the table of respectively described food product, feed product or medicine
At least the 5 × 10 of face5cfu/cm2.In a further embodiment, Lactobacillus paracasei bacterial strain CHCC14676 or its spread out
The concentration of raw mutant and/or the concentration of at least one Lactobacillus rhamnosus strain are respectively the food product, feeding
Expect at least the 1 × 10 of product or medicine8Cfu/g or respectively described food products, feed product or medicine at least 1 ×
108Cfu/ml, or at least the 1 × 10 of the surface of respectively described food product, feed product or medicine7cfu/cm2。
In a preferred embodiment, Fabrication parameter is controlled in the fabrication process so that Lactobacillus paracasei bacterial strain
The concentration of CHCC14676 (or its derivative mutant) and at least one Lactobacillus rhamnosus strain improves or kept permanent
It is fixed.
It is most readily by mixing with the food product, feed product or medicine that can be blended according to the antifungal composition of the present invention
Close and/or be applied on the food product that can be blended, feed product or medicine and use, still, handle solid food products
Surface for example should also be as being effective by the inside of injection treatment this kind of product.Also in other embodiments, described group
Compound can be used as marinade (marinade), breading (breading), wipe flavoring (seasoning rub), hanging
(glaze), coloring agent mixture etc. is applied, crucial standard be subjected to the surface of bacterial degradation and yeast and mould contamination can be with
Touch the antifungal composition.Also in other embodiments, by by composition be applied to packaging for foodstuff and then
By packaging applications in food surface, the composition can be contacted with food surface indirectly.The optimised quantity to be used will
Depending on by the composition of certain food product to be processed and method for composition to be applied to food surface, but can lead to
Cross simple experiment determination.
In a further preferred embodiment, methods described includes one or more fermentation steps, and at least one
Lactobacillus paracasei bacterial strain or the antifungal composition can quilts before, during or after one or more fermentation steps herein
It is added in food product, feed product or medicine.
Preferably, methods described be included in exist it is at least one according to the present invention Lactobacillus paracasei bacterial strain in the case of
With a period of time fermentation substrate, such as milk substrate, the time is sufficient so that at least one secondary cheese according to the present invention
Lactobacillus strain shows antifungal activity.This antifungal activity, which has, suppresses yeast and/or mould with least one
The effect grown in the product of strain fermentation.
In one even more preferably embodiment, methods described includes using starter culture cultured milk's substrate, described
Starter culture, which includes, to be selected from at least one bacterial strain of subordinate:Lactobacillus, streptococcus, lactococcus and leukonid
Category, such as at least one lactobacillus bulgaricus (Lactobacillus bulgaricus) bacterial strain and at least one thermophilus
Bacteria strain (Streptococcus thermophilus), or such as at least one Lactococcus lactis subsp. lactis
(Lactococcus lactis subsp.lactis) bacterial strain, at least one leuconostoc mesenteroides sub species cremoris
(Leuconostoc mesenteroides subsp.cremoris) bacterial strain and at least one Lactococcus lactis biacetyl subspecies
(Lactococcus lactis subsp.diacetylactis) bacterial strain.
The fifth aspect of the present invention is related to the food as obtained by method described according to the fourth aspect of the invention and produced
Product.
The sixth aspect of the present invention is related to according to the Lactobacillus paracasei bacterial strain of first aspect or according to the anti-of second aspect
Epiphyte composition is used for the purposes for preparing food product, feed product or medicine.Preferably, by using according to first aspect
Lactobacillus paracasei bacterial strain or the food product produced according to the antifungal composition of second aspect are cheese, such as Ka Teji
Cheese, it is luxuriant and rich with fragrance up to cheese, cut up to cheese, Palma cheese, cheese, angstrom door tal fibre cheese, red rich cheese, up to milk draw in Surrey
Cheese in junket, Ai Danmu cheese, Fei Dashi cheese, blue cheese, halogen cheese, card awns Bel cheese or cloth.
The last aspect of the present invention is related to according to the Lactobacillus paracasei bacterial strain of first aspect or according to the anti-of second aspect
Epiphyte composition is used for the purposes for suppressing the growth of yeast and mould, especially in food product and feed product.
Embodiment of the present invention is hereafter described by non-limiting example.
Embodiment
Embodiment 1:The Attack Research carried out with Lactobacillus paracasei CHCC14676 on Yoghourt
In order to which visual examination Lactobacillus paracasei bacterial strain CHCC14676 is for different moulds --- it is penicillium brevicompactum, common
Mould, aspergillus versicolor and light spore mould --- inhibition, be prepared for containing 1.5% fat Yoghourt:
Water-bath is heat-treated homogeneous milk (1.5% fat) 5 minutes in 1L bottle at 95 DEG C ± 1 DEG C, and cools down immediately.With
0.02% inoculation Commercial starter cultures (the F-DVS YF-L901 that can be obtained from the Chr.Hansen A/S of Denmark).With
HOLDBACTMYM-B (20DCU/100L) or Lactobacillus paracasei CHCC14676 (1 × 107CFU/ml milk) is further inoculated with, and
And a bottle is used as with reference to and is only inoculated with starter culture.
The cultured milk at 43 DEG C ± 1 DEG C is until pH reaches 4.60 ± 0.1.Obtained Yoghourt is poured into cup (100g)
And stored at 7 DEG C ± 1 DEG C.
After Yoghourt is prepared one day, it is inoculated into duplicate in equipment for prepn. of yoghurt using different moulds as surface contaminant,
A bacterial plaque is formed on Yoghourt surface, target is 100 spore/bacterial plaques.Visually rank is mould after being stored 45 days at 7 DEG C ± 1 DEG C
The growth of bacterium.
The result of Yoghourt test is presented in Fig. 1, and Fig. 1 shows penicillium brevicompactum (M1), penicillium communne (M6), aspergillus versicolor
(M7) (gone on top) or on Yoghourt prepared by the milk by being fermented using only starter culture YF-L901 by making with light spore mould (M8)
With starter culture and HOLDBACTM(center row) all grows well on Yoghourt prepared by the milk of YM-B cultures fermentation.Phase
Than under, when Lactobacillus paracasei CHCC14676 is present in milk fermentation process (bottom row), the growth of the mould of all tests
All it is inhibited by.
Embodiment 2:The quantitative determination of the inhibition of the Lactobacillus paracasei CHCC14676 confrontation inferior Dbaly yeasts of the Chinese
In order to which quantitative testing Lactobacillus paracasei CHCC14676 is for the inhibition of the inferior Dbaly yeast of the Chinese, it is prepared for
Yoghourt:
Water-bath is heat-treated homogeneous milk (1.5% fat) 5 minutes and cooled down immediately in 1L bottles at 95 DEG C ± 1 DEG C.With
0.02% inoculation Commercial starter cultures (the F-DVS YF-L901 that can be obtained from the Chr.Hansen A/S of Denmark).With
HOLDBACTM YM-B(20DCU/100L)、HOLDBACTMYM-C (10DCU/100L) or Lactobacillus paracasei CHCC14676 (1
×107CFU/g milk) is further inoculated with, and a bottle is used as with reference to and is only inoculated with starter culture.
The cultured milk at 43 DEG C ± 1 DEG C is until pH reaches 4.60 ± 0.1.Obtained Yoghourt is poured into cup (100g)
And stored at 7 DEG C ± 1 DEG C.
After Yoghourt is prepared one day, it is inoculated with duplicate in cup with the yeast of 1.00ml/ cups, target 20CFU/g.Will
Yeast is evenly dispersed into Yoghourt.Cup is closed the lid and is stored at 7 DEG C ± 1 DEG C, and in the following manner with it is suitable when
Between interval analyzed for the pollution level of the inferior Dbaly yeast of the Chinese:By 1ml Yoghourts with other in salt solution peptone
The 1 times of appropriate dilution plating prepared in (saline peptone) on yeast glucose chloramphenicol (YGC) agar,
Then oxygen supply is incubated 5 days at 25 DEG C.
As illustrated in figure 2, when being inoculated with before fermentation together with starter culture YF-L901, secondary cheese be present
In the case of lactobacillus strain CHCC14676, the growth of the inferior Dbaly yeast of the Chinese is suppressed.The bacterial strain is than commercially available culture
HOLDBACTMYM-B and HOLDBACTMYM-C causes significantly higher suppression.
Embodiment 3:Single Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC5366 and its combination confrontation
The semiquantitative determination of the inhibition of different mould contamination things
In order to carry out half to single Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC5366 and its combination
Quantitative testing, analyzed using agar, simulate the manufacturing process and product of Yoghourt:
Homogeneous milk (1.5%w/v fat) is heat-treated at 95 DEG C 5 minutes, and cooled down immediately.With 0.02% commercially available of inoculation
Sub- culture (the F-DVS YC-350 that can be obtained from the Chr.Hansen A/S of Denmark), and milk is assigned in 220ml bottles.
With 1 × 107CFU/ml total concentration is further inoculated with Lactobacillus paracasei CHCC14676, rhamnose breast bar respectively in bottle
The combination of bacterium CHCC5366 and both bacterial strains.Except the bottle that starter culture is not inoculated with further is used as joining
According to.In addition, the bromocresol purple of addition 5% and bromocresol green pH indicator are used to refer to acidification rate in all bottles
Show, and for making matrix obtain blue/green, this can more easily detect the subsequent growth for causing target yeast and mould.
All bottles are all incubated at 43 ± 1 DEG C in a water bath, and are fermented under these conditions until pH reaches 4.60 ± 0.1.Hair
After ferment, immediately cooled on ice bottle and acutely vibrate with crush coagulation.Then cultured milk is warming up to 40 DEG C of temperature
And be added in 40ml 5% sterile letheen solution, the sterile letheen solution has melted and has been cooled to 60 DEG C.Then will
The solution is poured into sterile petri dish, and dry flat board 30 minutes in LAF workbench.
By the selected mould suitably diluted receive ground mould (10 ×), penicillium communne (100 ×), aspergillus versicolor (100 ×) and
Skin falls the spore suspension point sample grown completely of mould (100 ×) to flat board.Flat board is incubated and with suitable and rule at 7 DEG C
The time interval of rule checks the growth of mould.
The result of agar analysis is presented in Fig. 3, and Fig. 3 shows the mould of all tests by being sent out using only starter culture
(reference) all very well grows on agar plate made from the milk of ferment.However, work as Lactobacillus paracasei CHCC14676 or sandlwood
When sugared lactobacillus CHCC5366 is present in milk fermentation process, obtained flat board consumingly reduces the growth of all moulds.In addition,
When Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC5366 combinations are present in milk fermentation process, it was observed that
Fall the even more strong suppression of mould particularly with the penicillium communne on point sample to flat board, aspergillus versicolor and skin.
Embodiment 4:Single Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC14226 and its combination pair
The semiquantitative determination of the inhibition of anti-different mould contamination thing
In order to be carried out to single Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC14226 and its combination
Sxemiquantitative is examined, and is analyzed using agar, is simulated the manufacturing process and product of Yoghourt:
Homogeneous milk (1.5%w/v fat) is heat-treated at 95 DEG C 5 minutes, and cooled down immediately.With 0.02% commercially available of inoculation
Sub- culture (the F-DVS that can be obtained from the Chr.Hansen A/S of DenmarkMild 220ml bottles), and by milk are assigned to
In son.With 1 × 107CFU/ml total concentration is further inoculated with Lactobacillus paracasei CHCC14676, rhamnose respectively in bottle
The combination of lactobacillus CHCC14226 and both bacterial strains.A bottle quilt not being inoculated with further except starter culture
As reference.In addition, the bromocresol purple of addition 5% and bromocresol green pH indicator are used to enter acidification rate in all bottles
Row instruction, and for making matrix obtain blue/green, this can more easily examine the subsequent growth for causing target yeast and mould
Survey.All bottles are all incubated at 43 ± 1 DEG C in a water bath, and are fermented under these conditions until pH reaches 4.60 ± 0.1.
After fermentation, immediately cooled on ice bottle and acutely vibrate with crush coagulation.Then cultured milk is warming up to 40 DEG C of temperature
Spend and be added in 40ml 5% sterile letheen solution, the sterile letheen solution has melted and has been cooled to 60 DEG C.Then
The solution is poured into sterile petri dish, and dry flat board 30 minutes in LAF workbench.
By the selected mould suitably diluted receive ground mould (10 ×), penicillium communne (100 ×), aspergillus versicolor (100 ×) and
Skin falls the spore suspension point sample grown up completely of mould (100 ×) to flat board.Flat board is incubated and with suitable and rule at 7 DEG C
The time interval of rule checks the growth of mould.
The result of agar analysis is presented in Fig. 4, and Fig. 4 shows the mould of all tests by being sent out using only starter culture
All very well grown on agar plate (reference) made from the milk of ferment.However, work as Lactobacillus paracasei CHCC14676 or sandlwood
When sugared lactobacillus CHCC14266 is present in milk fermentation process, obtained flat board consumingly reduces the growth of all moulds.In addition,
When Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC14266 combinations are present in milk fermentation process, it was observed that
Fall the even more strong suppression of mould for the penicillium communne on point sample to flat board, aspergillus versicolor and skin.
Embodiment 5:With the Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 of combination in Greek style acid
The Attack Research carried out on milk
The Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 combined for visual examination is for Mucor
The inhibition of category, Greek style Yoghourt is substantially prepared as follows:
With Commercial starter cultures (F-DVSYF-L901 that can be obtained from the Chr.Hansen A/S of Denmark) with 0.02%
It is inoculated with 1.5% fat milk of pasteurization.Only it is used as reference with a collection of of starter culture inoculation.Another batch is further used sandlwood
Sugared lactobacillus strain CHCC5366 (5 × 106) and Lactobacillus paracasei bacterial strain CHCC14676 (5 × 10 CFU/g6CFU/g group)
Splice grafting kind.
Cultured milk is to final pH 4.55 (6-7 hours) at 43 DEG C ± 1 DEG C.Then Yoghourt is cooled to 2 bars of back-pressure
25 DEG C ± 1 DEG C and it is stored in 6 DEG C ± 1 DEG C.
Prepared one day after in Yoghourt, by applying a bacterial plaque on Yoghourt surface, using mucor as surface contaminant one
Two parts of ground of formula are inoculated into equipment for prepn. of yoghurt, and target inoculum density is 100 spore/bacterial plaques.Mesh after being stored 15 days at 22 DEG C ± 1 DEG C
The growth of mould is estimated in test and appraisal.
The result of Greek style Yoghourt test is presented in Fig. 5, and Fig. 5 shows mucor by using only starter culture
Grown well on Yoghourt made from the milk of (left cup) fermentation.By contrast, as Lactobacillus rhamnosus CHCC5366 and secondary cheese
When lactobacillus CHCC14676 is present in milk fermentation process (right cup), the growth of mucor is suppressed.
Embodiment 6:With Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 combination in Greek style acid
Second of Attack Research on milk
In order to visual examination Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 combination for black root
The inhibition of mould (black bread mold) rhizopus stolonifer, Greek style Yoghourt is substantially prepared as follows:
With Commercial starter cultures (F-DVSYF-L901 that can be obtained from the Chr.Hansen A/S of Denmark) with 0.02%
It is inoculated with 1.5% fat milk of pasteurization.Use HOLDBACTMYM-B (10DCU/100L), use Lactobacillus rhamnosus strain
CHCC5366(1×107CFU/g), or with Lactobacillus rhamnosus strain CHCC5366 (5 × 106) and Lactobacillus paracasei CFU/g
Bacterial strain CHCC14676 (5 × 106CFU/g combination) is further inoculated with milk.It is a collection of to be used as with reference to and only connect with starter culture
Kind.
Cultured milk is to final pH 4.55 (6-7 hours) at 43 DEG C ± 1 DEG C.Then Yoghourt is cooled to 2 bars of back-pressure
25 DEG C ± 1 DEG C and it is stored in 6 DEG C ± 1 DEG C.
Prepared one day after in Yoghourt, by one bacterial plaque in way on Yoghourt surface, using rhizopus stolonifer as surface contaminant one
Two parts of ground of formula are inoculated into equipment for prepn. of yoghurt, and target stains are 100 spore/bacterial plaques.Estimate and comment after being stored 42 days at 7 DEG C ± 1 DEG C
Estimate the growth of mould.
The result of Greek style Yoghourt test is presented in Fig. 6, and Fig. 6 shows rhizopus stolonifer by using only starter culture
On Yoghourt made from the milk of fermentation (" R ", i.e. reference) or by using starter culture and HOLDBACTMYM-B cultures (YM-
B) grown well on Yoghourt made from the milk of fermentation.However, in the presence of Lactobacillus rhamnosus CHCC5366 (5366), branch of crawling
The growth of head mold is suppressed significantly.When Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 are present in milk
When in fermentation process (5366+14676), the growth of rhizopus stolonifer is almost totally constrained.
Embodiment 7:With the Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC12697 of combination in sour cream
On Attack Research
In order to visual examination Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC12697 combination for not
The inhibition of the growth of same mould, is substantially prepared for sour cream as follows:
(can be from Denmark with the commercially available heterofermentation starter culture of 0.01% inoculation in the high fat milk of pasteurization
The F-DVS DSG-2000 that Chr.Hansen A/S are obtained).Use HOLDBACTMYM-B (10DCU/100L) or with secondary cheese breast bar
Bacterium CHCC14676 (2.5 × 106) and Lactobacillus rhamnosus CHCC12697 (2.5 × 10 CFU/g6CFU/g combination) further connects
Kind milk.It is a collection of to be used as with reference to and be only inoculated with starter culture.
Cultured milk reaches 4.60 ± 0.05 until pH at 28 DEG C ± 1 DEG C, and sour cream is post-processed.Whisk yoghout
Oil is simultaneously cooled to 20 DEG C ± 1 DEG C and stored at 7 DEG C ± 1 DEG C.
It is dirty using different moulds as surface by applying a bacterial plaque in Yoghourt oil meter face after sour cream is prepared one day
Dye thing is inoculated into Yoghourt lubricating cup in duplicate, and aimed concn is 100 spore/bacterial plaques.Stored 61 days at 7 DEG C ± 1 DEG C
The growth of visually rank mould afterwards.
The result of sour cream test is presented in Fig. 7, and Fig. 7 shows penicillium brevicompactum (M1), penicillium communne (M6), variegated song
Mould (M7) and light spore mould (M8) is on sour cream made from the milk as being fermented using only starter culture (top row) or by using
Starter culture and HOLDBACTMAll grown well on sour cream (center row) made from the milk of YM-B cultures fermentation.Phase
Than under, when being present in Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC12697 in milk fermentation process
(bottom row), the growth of the mould of all tests are all inhibited by.
Embodiment 8:Lactobacillus paracasei CHCC14676 and Lactobacillus rhamnosus CHCC12697 combination confrontation sour cream
In the inferior Dbaly yeast of the Chinese inhibition quantitative determination.
For quantitative testing Lactobacillus paracasei bacterial strain CHCC14676 and Lactobacillus rhamnosus CHCC12697 combination pair
The inhibition of the anti-inferior Dbaly yeast of the Chinese, is substantially prepared for sour cream as follows:
(can be from Denmark with the commercially available heterofermentation starter culture of 0.01% inoculation in the high fat milk of pasteurization
The F-DVS DSG-2000 that Chr.Hansen A/S are obtained).Use HOLDBACTMYM-B (10DCU/100L) or with secondary cheese breast bar
Bacterium CHCC14676 (2.5 × 106) and Lactobacillus rhamnosus CHCC12697 (2.5 × 10 CFU/g6CFU/g combination) further connects
Kind milk.It is a collection of to be used as with reference to and be only inoculated with starter culture.
Cultured milk reaches 4.60 ± 0.05 until pH at 28 DEG C ± 1 DEG C, and sour cream is post-processed.Whisk yoghout
Oil is simultaneously cooled to 20 DEG C ± 1 DEG C and stored at 7 DEG C ± 1 DEG C.
After sour cream is prepared one day, the yeast of 1.00 milliliters/glass is inoculated into cup in duplicate, target is
20CFU/g.Yeast is evenly dispersed in sour cream.Cup is closed the lid and is stored in 7 DEG C ± 1 DEG C, and by with lower section
Formula is analyzed for the pollution level of the inferior Dbaly yeast of the Chinese at appropriate time intervals:By 1 milliliter of sour cream and in addition
The 1 times of appropriate dilution plating prepared in salt solution peptone is on yeast glucose chloramphenicol (YGC) agar, then
Oxygen supply is incubated 5 days at 25 DEG C.
As illustrated in figure 8, when being inoculated with before fermentation together with starter culture DSG-2000, secondary cheese be present
In the case of lactobacillus CHCC14676 and Lactobacillus rhamnosus CHCC12697 combination, the growth of the inferior Dbaly yeast of the Chinese by
Suppress.The bacterial strain is than commercially available culture HOLDBACTMYM-B causes significantly higher suppression.
Embodiment 9:With the Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 of combination in white halogen cheese
On Attack Research
For Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 the confrontation wine brewing of quantitative testing combination
The inhibition of yeast, it is prepared for white halogen cheese:
With Commercial starter cultures (the FD-DVS SafeIT-1 that can be obtained from the Chr.Hansen A/S of Denmark) with every
1000 liters of (l) milk 40U are inoculated with the milk of pasteurization and standardization.Use HOLDBACTMYM-B (10DCU/100L) uses rhamnose
Lactobacillus strain CHCC5366 (5 × 106) and Lactobacillus paracasei bacterial strain CHCC14676 (5 × 10 CFU/g6CFU/g combination)
Further it is inoculated with milk.It is a collection of to be used as with reference to and be only inoculated with starter culture.At 36 DEG C ± 1 DEG C, using Chy-Max plus (from
The Chr.Hansen A/S of Denmark are obtained) 90 points of rennet processing is carried out to milk with every 220 milliliters of 1000 liters (l) (ml)
Clock, then cut.In pH 6.0, by curdled milk with simultaneously discharge opeing is pumped into mould, to reach final pH 4.8-4.7
(20-24 hours).Cheese is added in the tank containing cold brine (8%) and stored at 5 DEG C ± 1 DEG C.
Prepare one day after, yeast is inoculated into the tank in duplicate, target 20CFU/ml in white halogen cheese.Will
Yeast is evenly dispersed in bittern.Cup is closed the lid and is stored at 7 DEG C ± 1 DEG C, for up to 40 days, and by with lower section
Formula is at appropriate time intervals for the pollution level analysis 10g of saccharomyces cerevisiae:Appropriate 1 that will be prepared in salt solution peptone
Times dilution plating is on yeast glucose chloramphenicol (YGC) agar, and then oxygen supply is incubated 5 days at 25 DEG C.
As illustrated in figure 9, when being inoculated with together with starter culture SafeIT-1, in the rhamnose breast bar that combination be present
In the case of bacterium CHCC5366 and Lactobacillus paracasei CHCC14676, the growth of saccharomyces cerevisiae is suppressed.The bacterial strain is than commercially available
Culture HOLDBACTMYM-B causes significantly higher suppression.
Embodiment 10:With the Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 of combination in white halogen milk
Second of Attack Research on junket
In order to which the Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 of quantitative testing combination resist mark
The inhibition of this kluyveromyces, as the description in embodiment 1 is prepared for white halogen cheese, the exception is that the tank uses horse
Gram this kluyveromyces are inoculated with as yeast pollutant:
As illustrated in Figure 10, when being inoculated with together with starter culture SafeIT-1, in the rhamnose breast that combination be present
In the case of bacillus CHCC5366 and Lactobacillus paracasei CHCC14676, the growth of kluyveromyces marxianus is suppressed.It is described
Bacterial strain is than commercially available culture HOLDBACTMYM-B causes significantly higher suppression.
Embodiment 11:With the Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 of combination in white halogen milk
Third time Attack Research on junket
It is common for Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei the CHCC14676 confrontation of visual examination combination
The inhibition of mould, as the description in embodiment 1 is prepared for white halogen cheese:
After white halogen cheese is prepared 7 days, cheese is removed from bittern, and using penicillium communne as surface contaminant one
Two parts of ground of formula are inoculated on cheese, three bacterial plaques are formed on cheese surface, target is 100 spore/bacterial plaques.At 7 DEG C ± 1 DEG C
Lower storage 12 days and after then being stored 16 days at 12 DEG C ± 1 DEG C, the life of the different penicillium communne separation strains of visually rank two
It is long.
The result of white halogen cheese test is presented in Figure 11, Figure 11 show two penicillium communne separation strains by using only
Grown well on white halogen cheese (left side) made from the milk of starter culture inoculation.By contrast, Lactobacillus rhamnosus is worked as
When CHCC5366 and Lactobacillus paracasei CHCC14676 are present in cheese production process (right side), the growth of penicillium communne is strong
Strong suppression.
Embodiment 12:With attacking for the confrontation Pan Shi moulds of Lactobacillus rhamnosus CHCC5366 and CHCC14676 on Yoghourt
Hit research
For the single Lactobacillus rhamnosus strain CHCC5366 of visual examination or itself and Lactobacillus paracasei CHCC14676
The inhibition for mould Pan Shi moulds is combined, is prepared for the Yoghourt containing 1.5% fat:
Water-bath is heat-treated homogeneous milk (1.5% fat) 5 minutes in 1L bottle at 95 DEG C ± 1 DEG C, and cools down immediately.With
0.02% inoculation Commercial starter cultures (the F-DVS YF-L901 that can be obtained from the Chr.Hansen A/S of Denmark).With
HOLDBACTMYM-B (20DCU/100L), individually use Lactobacillus rhamnosus CHCC5366 (1 × 107CFU/ml), or rhamnose is used
Lactobacillus CHCC5366 (5 × 106CFU/ml) with Lactobacillus paracasei CHCC14676 (5 × 106CFU/ml combination) is further
It is inoculated with milk.One bottle is used as with reference to and is only inoculated with starter culture.
The cultured milk at 43 DEG C ± 1 DEG C is until pH reaches 4.60 ± 0.1.Obtained Yoghourt is poured into cup (100g) simultaneously
Stored at 7 DEG C ± 1 DEG C.
After Yoghourt is prepared one day, it is inoculated into duplicate in equipment for prepn. of yoghurt using different moulds as surface contaminant,
A bacterial plaque is formed on Yoghourt surface, target is 100 spore/bacterial plaques.Visually rank is mould after being stored 28 days at 7 DEG C ± 1 DEG C
The growth of bacterium.
The result of Yoghourt test is presented in Figure 12, and Figure 12 shows Pan Shi moulds by using only starter culture YF-
Made from the milk of L901 fermentations on Yoghourt or by using starter culture and HOLDBACTMThe milk of YM-B cultures fermentation is made
Yoghourt on all grow well.By contrast, when Lactobacillus rhamnosus CHCC5366 is present in milk fermentation process, Pan Shi
The growth of mould is reduced strongly, moreover, Lactobacillus rhamnosus CHCC5366 and Lactobacillus paracasei CHCC14676 combination cause
The growth inhibition of even more strong Pan Shi moulds.
Embodiment 13:With Lactobacillus rhamnosus CHCC5366 and CHCC14676 under different storage temperatures on Yoghourt
Attack Research
For the single Lactobacillus rhamnosus strain CHCC5366 of visual examination or itself and Lactobacillus paracasei CHCC14676
Combination falls the inhibition of mould under different storage temperatures for mould skin, is prepared for the Yoghourt containing 1.5% fat:
Water-bath is heat-treated homogeneous milk (1.5% fat) 5 minutes in 1L bottle at 95 DEG C ± 1 DEG C, and cools down immediately.With
0.02% inoculation Commercial starter cultures (the F-DVS YF-L901 that can be obtained from the Chr.Hansen A/S of Denmark).With
HOLDBACTMYM-B (20DCU/100L), individually use Lactobacillus rhamnosus CHCC5366 (1 × 107CFU/ml), or rhamnose is used
Lactobacillus CHCC5366 (5 × 106CFU/ml) with Lactobacillus paracasei CHCC14676 (5 × 106CFU/ml combination) is further
It is inoculated with milk.One bottle is used as with reference to and is only inoculated with starter culture.
The cultured milk at 43 DEG C ± 1 DEG C is until pH reaches 4.60 ± 0.1.Obtained Yoghourt is poured into cup (100g) simultaneously
Stored at 7 DEG C ± 1 DEG C.
After Yoghourt is prepared one day, skin is fallen into mould and is inoculated into duplicate in equipment for prepn. of yoghurt as surface contaminant,
A bacterial plaque is formed on Yoghourt surface, target is 100 spore/bacterial plaques.At 7 DEG C ± 1 DEG C, 12 DEG C ± 1 DEG C or 22 DEG C ± 1 DEG C
The growth of visually rank mould after storing 36 days.
The result of Yoghourt test is presented in Figure 13, and Figure 13 shows that skin falls mould by using only starter culture YF-
Made from the milk of L901 fermentations on Yoghourt or by using starter culture and HOLDBACTMThe milk of YM-B cultures fermentation is made
Yoghourt on all grown well under all storage temperatures.By contrast, when Lactobacillus rhamnosus CHCC5366 individually or with
When Lactobacillus paracasei CHCC14676 combinations are present in milk fermentation process, stored 36 days at 7 DEG C ± 1 DEG C and 12 DEG C ± 1 DEG C
In the case of two kinds, the growth that skin falls mould is completely blocked.In the case of 22 DEG C of ± 1 DEG C of storages, skin falls being grown in for mould
Consumingly reduced in the case of Lactobacillus rhamnosus CHCC5366 being present, and Lactobacillus rhamnosus CHCC5366 and pair be present
Lactobacillus casei CHCC14676 is even more strongly reduced in the case of combining.
Preserved material and Expert Solutions
Applicant requires that before the grant date of this patent the sample of the conserving microorganism of following notice is only available for professional people
Scholar uses.
Lactobacillus paracasei bacterial strain CHCC14676 was deposited in German microorganism on 2 2nd, 2012 and cell culture is protected
Tibetan center (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH;DSMZ)
(Inhoffenstr.7B, D-38124Braunschweig) and it is designated deposit number DSM25612.
Lactobacillus rhamnosus strain CHCC5366 was deposited in German microorganism and cell culture on October 14th, 2009
Collection (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH;DSMZ)
(Inhoffenstr.7B, D-38124Braunschweig) and it is designated deposit number DSM23035.
Lactobacillus rhamnosus strain CHCC12697 is deposited in German microorganism on March 1st, 2011 and cell culture is protected
Tibetan center (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH;DSMZ)
(Inhoffenstr.7B, D-38124Braunschweig) and it is designated deposit number DSM24616.
Lactobacillus rhamnosus strain CHCC14226 was deposited in German microorganism and cell culture on March 15th, 2011
Collection (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH;DSMZ)
(Inhoffenstr.7B, D-38124Braunschweig) and it is designated deposit number DSM24562.
Preserved material was prepared according to " international recognition is used for the microbial preservation budapest treaty of proprietary program ".
Bibliography
US2011/0045134
EP1442113
EP11161609.0
Kosikowski, F.V. and Mistry, V.V., " Cheese and Fermented Milk Foods ",
1997, the third edition, F.V.Kosikowski, L.L.C.Westport, CT
Claims (20)
1. a kind of Lactobacillus paracasei (Lactobacillus paracasei) bacterial strain, it is to be protected with deposit number DSM25612
It is hidden in the Lactobacillus paracasei bacterial strain CHCC14676 of German microorganism and Cell Culture Collection.
2. a kind of antifungal composition, it includes Lactobacillus paracasei bacterial strain according to claim 1.
3. a kind of antifungal composition, it includes Lactobacillus paracasei bacterial strain according to claim 1 and at least one mouse
Lee's sugar lactobacillus (Lactobacillus rhamnosus) bacterial strain.
4. antifungal composition according to claim 3, wherein at least one Lactobacillus rhamnosus strain be selected from by
Group consisting of:The mouse that Lactobacillus rhamnosus CHCC12697 that deposit number is DSM24616, deposit number are DSM24652
Lee sugar lactobacillus CHCC14226 and Lactobacillus rhamnosus CHCC5366 that deposit number is DSM23035.
5. a kind of food product, its include Lactobacillus paracasei bacterial strain according to claim 1 or according to claim 2 to
Antifungal composition described in any one of 4.
6. food product according to claim 5, it includes the amount for effectively assigning the food product antifungal property
Lactobacillus paracasei bacterial strain according to claim 1.
7. according to the food product described in claim 5 or claim 6, wherein the food product is selected from what is consisted of
Group:Fruit and fruit derived product, vegetables and vegetables derived product, cereal and cereal derived product, dairy products and meat and its
Mixture.
8. according to the food product described in claim 5 or claim 6, wherein the food product is selected from what is consisted of
Group:Poultry and marine products class.
9. food product according to claim 7, wherein the food product is dairy products, and the dairy products are medium temperature
Fermented-milk products or hot fermentation dairy products.
10. food product according to claim 9, wherein the dairy products are Yoghourt or sour cream.
11. a kind of feed product, it includes Lactobacillus paracasei bacterial strain according to claim 1 or according to claim 2
To the antifungal composition described in any one of 4.
12. a kind of medicine, it includes Lactobacillus paracasei bacterial strain according to claim 1 or according in claim 2 to 4
Any one described in antifungal composition.
13. a kind of method for manufacturing food product, feed product or medicine, it includes in the fabrication process will be according to claim
Lactobacillus paracasei bacterial strain described in 1 or the antifungal composition according to any one of claim 2 to 4 are added to institute
State in food product, feed product or medicine, and control Fabrication parameter in the fabrication process so that the Lactobacillus paracasei bacterium
The concentration of strain keeps constant or improved.
14. according to the method for claim 13, wherein the concentration of the Lactobacillus paracasei bacterial strain is food production described in per g
Product, feed product or medicine at least 1 × 106Food product, feed product or medicine at least 1 described in cfu or respectively every ml ×
106Cfu, or per cm2The food product, the surface at least 1 × 10 of feed product or medicine5cfu。
15. according to the method for claim 13, it includes:
(a) added during the food product, feed product or medicine is manufactured according to any in claim 2 to 4
Antifungal composition described in so that at least one Lactobacillus rhamnosus strain and/or the Lactobacillus paracasei bacterium
The concentration of strain is respectively food product, feed product or medicine at least 1 × 10 described in per g6Cfu or per food product described in ml,
Feed product or medicine at least 1 × 106Cfu, or per cm2The food product, feed product or medicine surface at least 1 ×
105cfu;With
(b) Fabrication parameter is controlled in the fabrication process so that at least one Lactobacillus rhamnosus strain and/or the pair are dry
The concentration of Lactobacillus paracasei bacterial strain improves or keeps constant.
Walked 16. the method according to any one of claim 13 to 15, wherein methods described include one or more fermentations
Suddenly.
17. according to the method for claim 16, wherein methods described includes using starter culture cultured milk's substrate, described
Sub- culture, which includes, to be selected from at least one bacterial strain of subordinate:Lactobacillus (Lactobacillus) category, streptococcus
(Streptococcus) category, galactococcus (Lactococcus) category and leukonid (Leuconostoc) category.
18. Lactobacillus paracasei bacterial strain according to claim 1 or according to any one of claim 2 to 4
Antifungal composition is used for the purposes for preparing food product, feed product or medicine.
19. Lactobacillus paracasei bacterial strain according to claim 1 or according to any one of claim 2 to 4
Antifungal composition is used for the non-therapeutic use for suppressing the growth of fungi and mould.
20. Lactobacillus paracasei bacterial strain according to claim 1 or according to any one of claim 2 to 4
Purposes of the antifungal composition in the medicine for preparing the growth for being used for suppressing fungi and mould.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2012/056384 WO2012136830A1 (en) | 2011-04-08 | 2012-04-09 | Synergistic antimicrobial effect |
EP12163509 | 2012-04-09 | ||
EPPCT/EP2012/056384 | 2012-04-09 | ||
EP12163509.8 | 2012-04-09 | ||
EP12168971 | 2012-05-22 | ||
EP12168971.5 | 2012-05-22 | ||
PCT/EP2013/057400 WO2013153070A1 (en) | 2012-04-09 | 2013-04-09 | Bioprotection using lactobacillus paracasei strains |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104254599A CN104254599A (en) | 2014-12-31 |
CN104254599B true CN104254599B (en) | 2018-01-23 |
Family
ID=49327138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380018785.9A Active CN104254599B (en) | 2012-04-09 | 2013-04-09 | Using the biological protection of Lactobacillus paracasei bacterial strain |
Country Status (16)
Country | Link |
---|---|
US (2) | US10059919B2 (en) |
EP (1) | EP2836588B1 (en) |
JP (1) | JP6430930B2 (en) |
KR (1) | KR101949372B1 (en) |
CN (1) | CN104254599B (en) |
BR (1) | BR112014024014B1 (en) |
DK (1) | DK2836588T3 (en) |
EA (1) | EA034173B1 (en) |
ES (1) | ES2623768T3 (en) |
HK (1) | HK1206390A1 (en) |
HU (1) | HUE034411T2 (en) |
MX (1) | MX351627B (en) |
PL (1) | PL2836588T3 (en) |
PT (1) | PT2836588T (en) |
UA (1) | UA115331C2 (en) |
WO (1) | WO2013153070A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9462817B2 (en) | 2011-02-28 | 2016-10-11 | Franklin Foods Holdings Inc. | Processes for making cheese products utilizing denatured acid whey proteins |
US9635870B2 (en) | 2011-02-28 | 2017-05-02 | Franklin Foods Holdings Inc. | Direct-set cheese |
DK2693885T3 (en) | 2011-04-08 | 2018-05-22 | Chr Hansen As | Synergistic antimicrobial effect |
PT2836588T (en) | 2012-04-09 | 2017-05-25 | Chr Hansen As | Bioprotection using lactobacillus paracasei strains |
EP2836587B1 (en) | 2012-04-09 | 2017-03-01 | Chr. Hansen A/S | Bioprotection using lactobacillus rhamnosus strains |
GB201409468D0 (en) * | 2014-05-28 | 2014-07-09 | Dupont Nutrition Biosci Aps | Bacterium |
KR101532207B1 (en) * | 2014-10-02 | 2015-06-30 | 컴퍼니맨 주식회사 | Process for improving taste of greek yoghurt using fermentaion and whey protein separation on low temperature |
ITUB20152376A1 (en) * | 2015-07-07 | 2017-01-09 | Alfasigma Spa | LACTOBACILLUS PARACASEI FOR THE PRODUCTION OF CONJUGATED LINOLEIC ACID, NUTRITIONAL AND PHARMACEUTICAL PREPARATIONS THAT INCLUDE IT AND THEIR USE |
BR112018003474A2 (en) * | 2015-08-31 | 2018-09-25 | Chr Hansen As | lactobacillus fermentum bacteria that reduce acetaldehyde concentration |
BR112018003018A2 (en) * | 2015-08-31 | 2018-09-18 | Chr Hansen As | lactobacillus fermentum bacteria with antifungal activity |
US20180235248A1 (en) * | 2015-08-31 | 2018-08-23 | Chr. Hansen A/S | Lactobacillus fermentum bacteria inhibiting post-acidification |
EP3180990A1 (en) * | 2015-12-16 | 2017-06-21 | Neste Oyj | Method for preparing a composition having antimicrobial activity |
DK3279312T3 (en) * | 2016-08-02 | 2019-10-28 | Dsm Ip Assets Bv | BIOLOGICAL PROTECTION OF Dairy products |
CN110741073A (en) * | 2017-06-09 | 2020-01-31 | 曾根农场股份公司 | Novel lactic acid bacteria and use thereof |
KR101972838B1 (en) * | 2017-07-25 | 2019-04-29 | 호서대학교 산학협력단 | Fungicidal composition comprising the extract from Capsella bursa-pastoris and method for preparing the same |
MX2020010846A (en) * | 2018-04-19 | 2020-11-09 | Chr Hansen As | Inhibition of fungal growth by manganese depletion. |
US20220151267A1 (en) * | 2019-04-16 | 2022-05-19 | Locus Ip Company, Llc | Microbe-Based Emulsifying Food Additives |
EP3962291A1 (en) * | 2019-10-23 | 2022-03-09 | Chr. Hansen A/S | Bacterial composition for controlling fungal spoilage and uses thereof |
WO2022115709A2 (en) * | 2020-11-30 | 2022-06-02 | January, Inc. | Methods and composition for treating metabolic syndrome |
WO2023122035A2 (en) * | 2021-12-20 | 2023-06-29 | Solarea Bio, Inc. | Compositions and methods for producing enhanced crops with probiotics |
EP4248761A1 (en) * | 2022-03-24 | 2023-09-27 | Chr. Hansen A/S | Yeast inhibition with bacillus subtilis via iron depletion |
WO2023232677A1 (en) * | 2022-05-31 | 2023-12-07 | Lactobio A/S | Strains, compositions and methods of use |
NL2035175B1 (en) * | 2023-03-01 | 2024-03-25 | Chongqing Tianyou Dairy Co Ltd | Lactobacillus paracasei ty-f15 and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1308506A1 (en) * | 2001-11-06 | 2003-05-07 | Eidgenössische Technische Hochschule Zürich | Mixtures of Propionibacterium jensenii and Lactobacillus sp. with antimicrobial activities for use as a natural preservation system |
CN101768559A (en) * | 2008-12-31 | 2010-07-07 | 生展生物科技股份有限公司 | Lactobacillus, paracasei subsp. paracasei strain, bacteriostatic composition and applications thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965414A (en) | 1985-11-04 | 1999-10-12 | Microlife Technics, Inc. | Process for producing yeast and mold inhibiting products with lactobacillus |
US4956177A (en) | 1985-11-04 | 1990-09-11 | Microlife Technics, Inc. | Method for inhibiting fungi |
CA1320165C (en) * | 1987-08-06 | 1993-07-13 | Microlife Technics, Inc. | Process for producing novel yeast and mold inhibiting products |
JP3001338B2 (en) | 1992-06-10 | 2000-01-24 | ヴァリオ・マイイェリーン・ケスクソスースリーケ | Novel microbial strains, bacterial preparations containing the same, and the use of said strains and preparations for the control of yeast and mold |
FI92498C (en) | 1992-06-10 | 1994-11-25 | Valio Meijerien | New microorganism strain, bacterial preparations containing it and their use for controlling yeast and mold |
FR2758051B1 (en) | 1997-01-06 | 1999-12-17 | Cobiotex | METHODS FOR SYSTEMATICALLY ERADICATING THE CARRYING OF PATHOGENS BY ANIMALS AND COMPOSITIONS USED THEREIN |
EP1490077B1 (en) | 2002-02-21 | 2007-11-21 | Societe Des Produits Nestle S.A. | A photoprotective orally administrable composition for skin |
UA77066C2 (en) | 2002-02-21 | 2006-10-16 | Nestle Sa | Orally administrable composition for the photoprotection of the skin |
FI113057B (en) | 2002-11-04 | 2004-02-27 | Valio Oy | Use of Lactobacillus rhamnosus LGG deposited under ATCC 53103, Lactobacillus rhamnosus LC705, DSM 7061, and Propionibacterium freudenreichii PJS, DSM 7067 for preparing a product for inhibiting yeast |
ITRM20040166A1 (en) | 2004-03-31 | 2004-06-30 | Alberto Cresci | BACTERIAL STRAINS LAB WITH PROBIOTIC PROPERTIES AND COMPOSITIONS THAT CONTAIN THE SAME. |
WO2007140621A1 (en) | 2006-06-09 | 2007-12-13 | Nutravital Inc. | Probiotic compositions and uses thereof |
US20080107699A1 (en) * | 2006-10-25 | 2008-05-08 | Mark Spigelman | Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
EP1992351B1 (en) | 2007-05-18 | 2016-05-11 | Nestec S.A. | Lactobacillus johnsonii for prevention of postsurgical infection |
FR2924307B1 (en) | 2007-12-04 | 2010-08-27 | Gervais Danone Sa | USE OF L. CASEI SSP. PARACASEI AS ANTIFUNGAL |
CN101613667B (en) | 2009-07-23 | 2011-02-02 | 中国科学院微生物研究所 | Method for preparing L-lactic acid and special bacteria agent thereof |
WO2011141762A1 (en) | 2010-05-12 | 2011-11-17 | Compagnie Gervais Danone | Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei |
DK2693885T3 (en) | 2011-04-08 | 2018-05-22 | Chr Hansen As | Synergistic antimicrobial effect |
EP2836587B1 (en) | 2012-04-09 | 2017-03-01 | Chr. Hansen A/S | Bioprotection using lactobacillus rhamnosus strains |
PT2836588T (en) | 2012-04-09 | 2017-05-25 | Chr Hansen As | Bioprotection using lactobacillus paracasei strains |
-
2013
- 2013-04-09 PT PT137172375T patent/PT2836588T/en unknown
- 2013-04-09 UA UAA201412067A patent/UA115331C2/en unknown
- 2013-04-09 US US14/390,238 patent/US10059919B2/en active Active
- 2013-04-09 DK DK13717237.5T patent/DK2836588T3/en active
- 2013-04-09 KR KR1020147031571A patent/KR101949372B1/en active IP Right Grant
- 2013-04-09 EP EP13717237.5A patent/EP2836588B1/en active Active
- 2013-04-09 EA EA201491848A patent/EA034173B1/en not_active IP Right Cessation
- 2013-04-09 HU HUE13717237A patent/HUE034411T2/en unknown
- 2013-04-09 PL PL13717237T patent/PL2836588T3/en unknown
- 2013-04-09 MX MX2014012065A patent/MX351627B/en active IP Right Grant
- 2013-04-09 JP JP2015504931A patent/JP6430930B2/en active Active
- 2013-04-09 WO PCT/EP2013/057400 patent/WO2013153070A1/en active Application Filing
- 2013-04-09 ES ES13717237.5T patent/ES2623768T3/en active Active
- 2013-04-09 CN CN201380018785.9A patent/CN104254599B/en active Active
- 2013-04-09 BR BR112014024014-0A patent/BR112014024014B1/en active IP Right Grant
-
2015
- 2015-07-22 HK HK15107000.6A patent/HK1206390A1/en unknown
-
2018
- 2018-07-09 US US16/030,615 patent/US10767158B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1308506A1 (en) * | 2001-11-06 | 2003-05-07 | Eidgenössische Technische Hochschule Zürich | Mixtures of Propionibacterium jensenii and Lactobacillus sp. with antimicrobial activities for use as a natural preservation system |
CN101768559A (en) * | 2008-12-31 | 2010-07-07 | 生展生物科技股份有限公司 | Lactobacillus, paracasei subsp. paracasei strain, bacteriostatic composition and applications thereof |
Non-Patent Citations (1)
Title |
---|
DETECTION OF ANTIFUNGAL PROPERTIES IN LACTOBACILLUS PARACASEI SUBSP PARACASEI SM20,SM29, AND SM63 AND MOLECULAR TYPING OF THE STRAINS.;SCHWENNINGER S M.ET AL;《JOURNAL OF FOOD PROTECTION》;20051231;第68卷(第1期);111-119 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013153070A1 (en) | 2013-10-17 |
JP2015519042A (en) | 2015-07-09 |
US20150064152A1 (en) | 2015-03-05 |
HUE034411T2 (en) | 2018-02-28 |
BR112014024014B1 (en) | 2022-03-03 |
EP2836588B1 (en) | 2017-03-01 |
PT2836588T (en) | 2017-05-25 |
MX2014012065A (en) | 2014-11-21 |
CN104254599A (en) | 2014-12-31 |
EA034173B1 (en) | 2020-01-14 |
BR112014024014A2 (en) | 2017-06-20 |
DK2836588T3 (en) | 2017-05-22 |
KR101949372B1 (en) | 2019-02-18 |
ES2623768T3 (en) | 2017-07-12 |
EP2836588A1 (en) | 2015-02-18 |
US10059919B2 (en) | 2018-08-28 |
US20160068800A9 (en) | 2016-03-10 |
PL2836588T3 (en) | 2017-08-31 |
HK1206390A1 (en) | 2016-01-08 |
KR20140148480A (en) | 2014-12-31 |
US20190010445A1 (en) | 2019-01-10 |
MX351627B (en) | 2017-10-23 |
JP6430930B2 (en) | 2018-11-28 |
EA201491848A1 (en) | 2015-01-30 |
UA115331C2 (en) | 2017-10-25 |
US10767158B2 (en) | 2020-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104254599B (en) | Using the biological protection of Lactobacillus paracasei bacterial strain | |
CN104284975B (en) | The biological protection of application Lactobacillus rhamnosus strain | |
CN103596435B (en) | synergistic antimicrobial effect | |
US11096396B2 (en) | Lactobacillus fermentum bacteria with antifungal activity | |
CN108347952A (en) | The lactobacillus fermenti bacterium being acidified after inhibition | |
US20230189831A1 (en) | Bioprotective lactic acid bacteria with low postacidification | |
WO2024141408A1 (en) | Bioprotective lacticaseibacillus rhamnosus with low postacidification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |